Caspase polymorphisms and prognosis of hepatocellular carcinoma.

Caspase polymorphisms and prognosis of hepatocellular carcinoma.

The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC). We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of...

Full description

Bibliographic Details
Main Authors:	Song Zhang, Qianyi Xiao, Zhuqing Shi, Guopeng Yu, Xiao-Pin Ma, Haitao Chen, Pengyin Zhang, Suqin Shen, He-Xi Ge Sai-Yin, Tao-Yang Chen, Pei-Xin Lu, Neng-Jin Wang, Weihua Ren, Peng Huang, Jun Xie, Carly Conran, S Lilly Zheng, Long Yu, Jianfeng Xu, De-Ke Jiang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5409165?pdf=render

Similar Items

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer
by: Carly A Conran, et al.
Published: (2016-01-01)

Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma
by: Deke Jiang, et al.
Published: (2020-05-01)

Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.
by: Pei-Feng Liu, et al.
Published: (2017-01-01)

Caspase-2 in liver disease and hepatocellular carcinoma
by: Amaya Lopez-Pascual, et al.
Published: (2022-10-01)

Assessing the clinical utility of genetic risk scores for targeted cancer screening
by: Carly A. Conran, et al.
Published: (2021-01-01)

Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.
by: Yu-Qin Zhang, et al.
Published: (2013-01-01)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
by: Shi-yi Wu, et al.
Published: (2022-06-01)

Prognosis of microwave ablation for hepatocellular carcinoma: does age make a difference?
by: Yi-Xuan Zhang, et al.
Published: (2020-01-01)

Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients
by: Shengnan Wang, et al.
Published: (2024-01-01)

Personalized prostate cancer care: from screening to treatment
by: Carly A Conran, et al.
Published: (2016-01-01)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
by: Yibing Chen, et al.
Published: (2018-12-01)

Application of Deep Learning in Cancer Prognosis Prediction Model
by: Heng Zhang MS, et al.
Published: (2023-09-01)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
by: Qun Cai, et al.
Published: (2022-01-01)

Correction to: Molecular pattern of lncRNAs in hepatocellular carcinoma
by: Haoming Mai, et al.
Published: (2019-08-01)

Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma
by: Junjie Jiang, et al.
Published: (2021-08-01)

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
by: Yin-wei Dai, et al.
Published: (2022-09-01)

High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma
by: Xi Chen, et al.
Published: (2022-06-01)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
by: Xiao Wang, et al.
Published: (2022-01-01)

Expression levels of caspase‐3 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer
by: Yuan‐Li Huang, et al.
Published: (2022-09-01)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
by: Jingjing Xiao, et al.
Published: (2022-08-01)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
by: Xinyu Zheng, et al.
Published: (2023-03-01)

RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
by: Haiyuan Li, et al.
Published: (2023-01-01)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
by: Kequan Xu, et al.
Published: (2022-12-01)

Expressions of miR-96 and miR-103 in Hepatocellular Carcinoma and Their Correlation with Prognosis
by: XIAO Wei, et al.
Published: (2020-06-01)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
by: Hao Zhang, et al.
Published: (2021-11-01)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
by: Zaoqu Liu, et al.
Published: (2023-02-01)

Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
by: Li, Y, et al.
Published: (2024)

Caspase-11 signaling enhances graft-versus-host disease
by: Yanyan Lu, et al.
Published: (2019-09-01)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
by: Zhang Guizhen, et al.
Published: (2023-01-01)

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2017-06-01)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
by: Jingjuan Zhu, et al.
Published: (2023-03-01)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
by: Xin-Yu Ge, et al.
Published: (2023-03-01)

Lens-specific deletion of the gene increased apoptosis by enhancing the caspase-3/caspase-8 signaling pathway
by: Ziyan Yu, et al.
Published: (2018-07-01)

ATIVAÇÃO DE CASPASE-1 CONTRIBUI PARA INTERAÇÕES LEUCÓCITOS-ENDOTÉLIO INDUZIDAS PELA HEMÓLISE INTRAVASCULAR
by: PL Brito, et al.
Published: (2023-10-01)

A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma
by: Shengjie Yang, et al.
Published: (2022-07-01)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2023-10-01)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
by: Yongwei Chen, et al.
Published: (2023-03-01)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
by: Yu Li, et al.
Published: (2023-01-01)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
by: Zhong‐Guo Zhou, et al.
Published: (2020-08-01)

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
by: Hong Yang, et al.
Published: (2017-03-01)